LU76417A1 - - Google Patents

Info

Publication number
LU76417A1
LU76417A1 LU76417A LU76417A LU76417A1 LU 76417 A1 LU76417 A1 LU 76417A1 LU 76417 A LU76417 A LU 76417A LU 76417 A LU76417 A LU 76417A LU 76417 A1 LU76417 A1 LU 76417A1
Authority
LU
Luxembourg
Application number
LU76417A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU76417A1 publication Critical patent/LU76417A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
LU76417A 1975-12-19 1976-12-17 LU76417A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2557425A DE2557425C2 (de) 1975-12-19 1975-12-19 11-Oxo-11-H-pyrido[2,1-b]-chinazolin-2-carbonsäure und ihre Salze, Verfahren zu ihrer Herstellung und Arzneimittel

Publications (1)

Publication Number Publication Date
LU76417A1 true LU76417A1 (en:Method) 1978-01-18

Family

ID=5964943

Family Applications (1)

Application Number Title Priority Date Filing Date
LU76417A LU76417A1 (en:Method) 1975-12-19 1976-12-17

Country Status (36)

Country Link
US (2) US4083980A (en:Method)
JP (1) JPS5831350B2 (en:Method)
AT (1) AT352736B (en:Method)
AU (1) AU513469B2 (en:Method)
BE (1) BE849542A (en:Method)
BG (3) BG25093A3 (en:Method)
CA (1) CA1199914A (en:Method)
CH (4) CH627754A5 (en:Method)
CS (1) CS198222B2 (en:Method)
DD (1) DD128812A5 (en:Method)
DE (1) DE2557425C2 (en:Method)
DK (1) DK149107C (en:Method)
ES (3) ES454405A1 (en:Method)
FI (1) FI64159C (en:Method)
FR (1) FR2335229A1 (en:Method)
GB (1) GB1572707A (en:Method)
GR (1) GR62109B (en:Method)
HK (1) HK12984A (en:Method)
HU (1) HU172929B (en:Method)
IE (1) IE45256B1 (en:Method)
IL (1) IL51124A (en:Method)
LU (1) LU76417A1 (en:Method)
MX (1) MX4488E (en:Method)
MY (1) MY8500078A (en:Method)
NL (1) NL182535C (en:Method)
NO (1) NO147450C (en:Method)
NZ (1) NZ182915A (en:Method)
PH (1) PH16310A (en:Method)
PL (5) PL103556B1 (en:Method)
PT (1) PT65981A (en:Method)
RO (3) RO75734A (en:Method)
SE (1) SE431456B (en:Method)
SG (1) SG55483G (en:Method)
SU (4) SU645571A3 (en:Method)
YU (2) YU39048B (en:Method)
ZA (1) ZA767490B (en:Method)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337255A (en) * 1977-07-29 1982-06-29 E. R. Squibb & Sons, Inc. Pyrazolo[1,5-c]quinazoline derivatives and related compounds
HU182009B (en) * 1977-08-19 1983-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing substituted pirido-square bracket-1,2-a-square bracket closed-pyrimidines, pyrrolo-square bracket-1,2-a-square bracket closed-pyrimidines
DE2739020A1 (de) 1977-08-26 1979-03-01 Schering Ag Pyrido eckige klammer auf 2,1-b eckige klammer zu -chinazolinon-derivate, ihre herstellung und verwendung
US4348396A (en) * 1978-01-23 1982-09-07 Hoffmann-La Roche Inc. Substituted 11-oxo-11H-pyrido[2,1-b]quinazolines and method of inhibiting allergic reactions with them
US4168380A (en) * 1978-04-21 1979-09-18 Hoffmann-La Roche Inc. 7-Methoxy-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones
US4491587A (en) * 1978-05-05 1985-01-01 Mead Johnson & Company Tetrazole derivatives
US4209620A (en) * 1978-06-19 1980-06-24 Bristol-Myers Company Substituted 3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives having antiallergy activity
DE2845766A1 (de) * 1978-10-18 1980-04-30 Schering Ag Pyrido eckige klammer auf 2,1-b eckige klammer zu -chinazolinon-derivate, ihre herstellung und verwendung
EP0015065B1 (en) * 1979-01-24 1983-12-28 Warner-Lambert Company Pyrazolo (5,1-b) quinazolin-9(4h)-one derivatives, process for their preparation and pharmaceutical compositions containing them
US4282360A (en) * 1979-10-12 1981-08-04 Hoffmann-La Roche Inc. 7-Methylthio or methylsulfinyl-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid
US4302585A (en) 1980-12-22 1981-11-24 American Home Products Corporation 3-Hydroxy-3-substituted phenylthiazolo[2,3-b]quinazoline-2-alkanoic acids and their lactones
US4395549A (en) 1981-10-02 1983-07-26 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. 6-Hydrazono-pyrido[2,1-b] quinazoline-11 ones
DE3142728A1 (de) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen Herbizide, enthaltend thiazolo(2,3-b)-chinazolone als wirkstoffe, und ihre verwendung zur beeinflussung des pflanzenwachstums
DE3142727A1 (de) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen Thiazolo (2,3-b)-chinazolone, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des pflanzenwachstums
ES8406476A1 (es) * 1982-04-29 1984-07-01 Erba Farmitalia Procedimiento para preparar derivados cicloalifaticos condensados de pirido(1,2-a)pirimidinas sustituidas.
US4551460A (en) * 1982-05-10 1985-11-05 Hoffmann-La Roche Inc. Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis
US4455312A (en) * 1982-08-19 1984-06-19 Portnyagina Vera A 2-(o-Carboxyphenylamino)-6H-pyrimido(2,1-b)-quinazolone-6 and derivatives thereof, and application as antiphlogistics
DE3300477A1 (de) * 1983-01-08 1984-07-12 Boehringer Ingelheim KG, 6507 Ingelheim Neue heterocyclische verbindungen, ihre herstellung und verwendung
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
EP0142057A3 (en) * 1983-11-04 1988-03-30 F. Hoffmann-La Roche Ag Thiazoloquinazoline derivatives, their preparation and pharmaceutical compositions containing same
US4588812A (en) * 1984-05-30 1986-05-13 Pennwalt Corporation Substituted 2,3-dihydro-5H-thiazolo[2,3,-b]quinazoline derivatives
US4738964A (en) * 1984-05-30 1988-04-19 Pennwalt Corporation Method of suppressing the immune system comprising administering 5H-thiazolo[2,3-b]quinazoline-3(2H)-one
DE3634532A1 (de) * 1986-10-10 1988-04-14 Basf Ag Verfahren zur herstellung von thiazolo-(2,3-b)chinazolonen
DE3704203A1 (de) * 1987-02-11 1988-08-25 Boehringer Ingelheim Kg Verwendung von oxochinazolinderivaten bei der behandlung der hyperurikaemie
US4904667A (en) * 1989-02-24 1990-02-27 Ortho Pharmaceutical Corporation 1H-1,2,4-thiadiazolo(3,4-b)quinazolin-5-one-2,2-dioxides, and a method for increasing the cardiac output of a mammal with them
US6800651B2 (en) 2000-02-03 2004-10-05 Eli Lilly And Company Potentiators of glutamate receptors
WO2011130163A1 (en) 2010-04-12 2011-10-20 Millennium Pharmaceuticals, Inc. Substituted hydroxamic acids and uses thereof
WO2012054332A1 (en) 2010-10-18 2012-04-26 Millennium Pharmaceuticals, Inc. Substituted hydroxamic acids and uses thereof
WO2016126726A1 (en) 2015-02-02 2016-08-11 Forma Therapeutics, Inc. Bicyclic [4,6,0] hydroxamic acids as hdac6 inhibitors
WO2016126721A1 (en) 2015-02-02 2016-08-11 Forma Therapeutics, Inc. 3-aryl-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
EP3472131B1 (en) 2016-06-17 2020-02-19 Forma Therapeutics, Inc. 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242863A (en) * 1968-05-10 1971-08-18 Pharmacia As 2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF
US3598823A (en) * 1969-05-28 1971-08-10 Sandoz Ag Tricyclic quinazolinones
US3833588A (en) * 1972-04-25 1974-09-03 Sandoz Ag Unsaturated-substituted tricyclic quinazolinones
JPS5752352B2 (en:Method) * 1974-02-28 1982-11-06
US4012387A (en) * 1975-09-18 1977-03-15 Warner-Lambert Company Benzo-[g]pyrido[2,1-b]quinazolinones
US4033961A (en) * 1975-10-07 1977-07-05 Warner-Lambert Company Pyrido[2-1-b]quinazolin-ones and their methods of preparation
US4142049A (en) * 1976-10-18 1979-02-27 Warner-Lambert Company Benzo[g]pyrido[2,1-b]quinazolinones
US4066767A (en) * 1976-11-01 1978-01-03 Warner-Lambert Company 8-(1H-Tetrazol-5-yl)-11H-pyrido[2,1-b]quinazolin-11-ones and method of treating bronchial asthma using them
ES468126A1 (es) * 1977-03-24 1979-09-01 Hoffmann La Roche Un procedimiento para la preparacion de nuevos derivados de pirido(2,1b) quinazolina
DE2739020A1 (de) * 1977-08-26 1979-03-01 Schering Ag Pyrido eckige klammer auf 2,1-b eckige klammer zu -chinazolinon-derivate, ihre herstellung und verwendung
US4168380A (en) * 1978-04-21 1979-09-18 Hoffmann-La Roche Inc. 7-Methoxy-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid

Also Published As

Publication number Publication date
BG24673A3 (bg) 1978-04-12
ES464162A1 (es) 1978-09-01
BG25093A3 (bg) 1978-07-12
SU645571A3 (ru) 1979-01-30
FI763469A7 (en:Method) 1977-06-20
IE45256L (en) 1977-06-19
DE2557425C2 (de) 1987-03-19
NO764303L (en:Method) 1977-06-21
ZA767490B (en) 1978-08-30
IL51124A (en) 1980-06-30
RO75248A (ro) 1980-11-30
DK149107B (da) 1986-01-27
HU172929B (hu) 1979-01-28
NL182535B (nl) 1987-11-02
PL110780B1 (en) 1980-07-31
PL103556B1 (pl) 1979-06-30
SE7614258L (sv) 1977-06-20
PH16310A (en) 1983-09-05
GB1572707A (en) 1980-07-30
SU652894A3 (ru) 1979-03-15
FI64159C (fi) 1983-10-10
SE431456B (sv) 1984-02-06
MY8500078A (en) 1985-12-31
NO147450C (no) 1983-04-13
JPS5831350B2 (ja) 1983-07-05
DK149107C (da) 1986-06-09
RO69411A (ro) 1982-02-01
GR62109B (en) 1979-02-26
SU784776A3 (ru) 1980-11-30
US4083980A (en) 1978-04-11
PL101141B1 (pl) 1978-12-30
YU308276A (en) 1982-08-31
AT352736B (de) 1979-10-10
ATA883976A (de) 1979-03-15
AU2069576A (en) 1978-06-22
AU513469B2 (en) 1980-12-04
YU115282A (en) 1983-12-31
NL182535C (nl) 1988-04-05
YU39048B (en) 1984-02-29
CA1199914A (en) 1986-01-28
DE2557425A1 (de) 1977-06-30
ES454405A1 (es) 1978-01-16
PT65981A (pt) 1977-01-01
NZ182915A (en) 1979-07-11
MX4488E (es) 1982-05-21
CH625522A5 (en:Method) 1981-09-30
PL102308B1 (pl) 1979-03-31
HK12984A (en) 1984-02-24
CH631983A5 (de) 1982-09-15
CS198222B2 (en) 1980-05-30
FR2335229B1 (en:Method) 1980-04-11
ES464136A1 (es) 1978-09-01
FR2335229A1 (fr) 1977-07-15
NO147450B (no) 1983-01-03
CH625243A5 (en:Method) 1981-09-15
BG25092A3 (bg) 1978-07-12
US4332802A (en) 1982-06-01
DD128812A5 (de) 1977-12-14
IE45256B1 (en) 1982-07-28
FI64159B (fi) 1983-06-30
DK567376A (da) 1977-06-20
PL111422B1 (en) 1980-08-30
CH627754A5 (de) 1982-01-29
SG55483G (en) 1984-07-27
JPS5277096A (en) 1977-06-29
RO75734A (ro) 1982-07-06
SU733516A3 (ru) 1980-05-05
YU40078B (en) 1985-06-30
IL51124A0 (en) 1977-02-28
NL7614013A (nl) 1977-06-21
BE849542A (fr) 1977-06-17

Similar Documents

Publication Publication Date Title
FR2335229B1 (en:Method)
JPS5523558B2 (en:Method)
JPS5191652U (en:Method)
JPS51121310U (en:Method)
JPS51129247U (en:Method)
JPS51137752U (en:Method)
BG21749A1 (en:Method)
CH603263A5 (en:Method)
CH575592A5 (en:Method)
CH599019A5 (en:Method)
CH601833A5 (en:Method)
CH603493A5 (en:Method)
CH596331A5 (en:Method)
CH599497A5 (en:Method)
CH600083A5 (en:Method)
BG21435A1 (en:Method)
CH596119A5 (en:Method)
CH602830A5 (en:Method)
CH599265A5 (en:Method)
CH597750A5 (en:Method)
BG21530A1 (en:Method)
CH595962A5 (en:Method)
CH601869A5 (en:Method)
CH599899A5 (en:Method)
CH602160A5 (en:Method)